(Reuters) - A unanimous U.S. Supreme Court on Thursday prohibited patents on naturally occurring human genes but allowed legal protections on synthetically produced genetic material in a compromise ruling hailed as a partial victory for patients and the biotechnology industry.
The ruling by the nine justices, the first of its kind for the top U.S.court, buttressed important patent protections relied upon by biotechnology companies while making it clear that genes extracted from the human body cannot be patented.
Researchers and advocates for patients said it could make it easier for people to get cheaper genetic tests for disease risk.
SCOTUS---Supreme Court Allows Warrantless Collection of DNA by Police/5-4 Ruling
SCOTUS---The American Police State
SCOTUS showdown over Voting Rights Act
SCOTUS---Farmer vs. Monsanto
SCOTUS---Dog's sniff was up to snuff
Oregon Supreme Court decided to erode more of the 4th Amendment
SCOTUS refuses to hear “piracy” arguments
SCOTUS declines death penalty case
SCOTUS revives challenge to ObamaCare & rejects appeal of congressman
SCOTUS denies Ohio request to curtail early voting